Epidemiological Trends in Pediatric Osteoporosis

Abstract

Recent advances include understanding bone fragility's genetic and molecular basis and discovering acquired causes of pediatric osteoporosis. Genetic pediatric bone defects are common and morbid, causing osteoporosis. Due to the rising prevalence of chronic diseases like Duchenne muscular dystrophy and immobility, as well as the use of drugs like steroids that can damage bones, secondary osteoporosis in children is rising.  Early detection of osteoporosis in children is essential for diagnosis and treatment. Dual-energy X-ray absorptiometry (DXA) and peripheral quantitative computed tomography (pQCT) scan for bone densitometry and vertebral fractures in pediatric osteoporosis patients. Pediatric osteoporosis requires a comprehensive team of bone disease specialists. A specialist should prevent and cure fragility fractures and improve patients' quality of life. Bisphosphonates, the most often recommended drugs for children, enhance BMD and restructure spinal fractures when given promptly. Raising awareness of osteoporosis risk factors, screening youngsters, and referring them to a specialist can detect silent fractures early and avoid bone degeneration. This article reviews childhood osteoporosis and its epidemiology. The global sickness classification and study program are briefly explained.